Paul Knight
Stock Analyst at KeyBanc
(3.62)
# 2,192
Out of 5,128 analysts
260
Total ratings
44.4%
Success rate
4.6%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRVI Maravai LifeSciences Holdings | Upgraded: Buy | $11 | $7.86 | +39.95% | 10 | Nov 12, 2026 | |
| CSTL Castle Biosciences | Reiterated: Buy | $35 → $40 | $34.42 | +16.21% | 10 | Nov 6, 2026 | |
| CYRX Cryoport | Reiterated: Buy | $17 → $20 | $20.74 | -3.57% | 11 | Nov 6, 2026 | |
| TKNO Alpha Teknova | Reiterated: Hold | n/a | $8.73 | - | 6 | Nov 5, 2026 | |
| WAT Waters | Reiterated: Buy | $460 → $500 | $475.52 | +5.15% | 10 | Nov 4, 2026 | |
| STVN Stevanato Group | Reiterated: Buy | $32 → $25 | $13.53 | +84.77% | 8 | Nov 3, 2026 | |
| RGEN Repligen | Reiterated: Buy | $220 | $173.98 | +26.45% | 14 | Oct 28, 2026 | |
| RVTY Revvity | Reiterated: Buy | $125 → $165 | $159.10 | +3.71% | 13 | Sep 4, 2026 | |
| LFCR Lifecore Biomedical | Reiterated: Hold | n/a | $6.37 | - | 4 | Aug 6, 2026 | |
| WST West Pharmaceutical Services | Reiterated: Buy | $350 → $390 | $412.55 | -5.47% | 16 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $0.7534 | +563.66% | 3 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $72.82 | - | 19 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $10 | $5.26 | +90.11% | 11 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.665 | - | 9 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $310 | $236.11 | +31.29% | 9 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $750 | $718.20 | +4.43% | 9 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €415.00 → €320.00 | €290.70 | n/a | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 | $144.12 | n/a | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | CHF 525.00 | CHF 394.60 | n/a | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $177.88 | n/a | 12 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $30 | $15.57 | n/a | 3 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $30 | $9.26 | n/a | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $31.22 | n/a | 2 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $136.91 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 610.00 → CHF 635.00 | CHF 661.00 | n/a | 6 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $40.48 | n/a | 9 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 | $345.80 | n/a | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 | $275.15 | n/a | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.47 | n/a | 6 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $30 | $16.96 | n/a | 3 | Feb 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $2 | $0.01 | n/a | 8 | Nov 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.75 | n/a | 2 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $24.06 | n/a | 7 | Nov 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $214.91 | n/a | 6 | Oct 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $62.24 | n/a | 4 | Mar 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.7948 | n/a | 2 | Mar 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $80.77 | n/a | 1 | Feb 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $75 → $85 | $236.90 | n/a | 2 | Jul 24, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $1.37 | n/a | 1 | May 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $61 → $46 | $11.67 | n/a | 2 | Dec 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $255 | $1,751.38 | n/a | 1 | Aug 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $24 | $50.51 | n/a | 1 | Aug 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $18 | $0.64 | n/a | 1 | Aug 15, 2013 |
Maravai LifeSciences Holdings
Nov 12, 2026
Upgraded: Buy
Price Target: $11
Current: $7.86
Upside: +39.95%
Castle Biosciences
Nov 6, 2026
Reiterated: Buy
Price Target: $35 → $40
Current: $34.42
Upside: +16.21%
Cryoport
Nov 6, 2026
Reiterated: Buy
Price Target: $17 → $20
Current: $20.74
Upside: -3.57%
Alpha Teknova
Nov 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $8.73
Upside: -
Waters
Nov 4, 2026
Reiterated: Buy
Price Target: $460 → $500
Current: $475.52
Upside: +5.15%
Stevanato Group
Nov 3, 2026
Reiterated: Buy
Price Target: $32 → $25
Current: $13.53
Upside: +84.77%
Repligen
Oct 28, 2026
Reiterated: Buy
Price Target: $220
Current: $173.98
Upside: +26.45%
Revvity
Sep 4, 2026
Reiterated: Buy
Price Target: $125 → $165
Current: $159.10
Upside: +3.71%
Lifecore Biomedical
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.37
Upside: -
West Pharmaceutical Services
Jul 2, 2026
Reiterated: Buy
Price Target: $350 → $390
Current: $412.55
Upside: -5.47%
May 29, 2026
Reiterated: Buy
Price Target: $8 → $5
Current: $0.7534
Upside: +563.66%
May 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $72.82
Upside: -
Mar 11, 2026
Reiterated: Buy
Price Target: $15 → $10
Current: $5.26
Upside: +90.11%
Feb 25, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.665
Upside: -
Dec 18, 2025
Rated: Buy
Price Target: $310
Current: $236.11
Upside: +31.29%
Dec 8, 2025
Upgraded: Buy
Price Target: $750
Current: $718.20
Upside: +4.43%
Oct 7, 2025
Reiterated: Buy
Price Target: €415.00 → €320.00
Current: €290.70
Upside: n/a
Sep 10, 2025
Reiterated: Buy
Price Target: $220
Current: $144.12
Upside: n/a
Sep 4, 2025
Initiated Coverage: Buy
Price Target: CHF 525.00
Current: CHF 394.60
Upside: n/a
Aug 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $177.88
Upside: n/a
Jun 3, 2025
Reiterated: Buy
Price Target: $40 → $30
Current: $15.57
Upside: n/a
Apr 9, 2025
Downgraded: Hold
Price Target: $7 → $30
Current: $9.26
Upside: n/a
Mar 31, 2025
Downgraded: Hold
Price Target: n/a
Current: $31.22
Upside: n/a
Feb 5, 2025
Reiterated: Hold
Price Target: n/a
Current: $136.91
Upside: n/a
Jan 30, 2025
Reiterated: Buy
Price Target: CHF 610.00 → CHF 635.00
Current: CHF 661.00
Upside: n/a
Nov 14, 2023
Rated: Hold
Price Target: n/a
Current: $40.48
Upside: n/a
May 5, 2022
Reiterated: Buy
Price Target: $300
Current: $345.80
Upside: n/a
Apr 28, 2022
Reiterated: Buy
Price Target: $250
Current: $275.15
Upside: n/a
Mar 14, 2022
Downgraded: Hold
Price Target: n/a
Current: $2.47
Upside: n/a
Feb 27, 2020
Reiterated: Hold
Price Target: $20 → $30
Current: $16.96
Upside: n/a
Nov 26, 2019
Downgraded: Hold
Price Target: $6 → $2
Current: $0.01
Upside: n/a
Jul 24, 2019
Downgraded: Hold
Price Target: n/a
Current: $4.75
Upside: n/a
Nov 29, 2018
Downgraded: Hold
Price Target: n/a
Current: $24.06
Upside: n/a
Oct 23, 2017
Upgraded: Hold
Price Target: n/a
Current: $214.91
Upside: n/a
Mar 27, 2017
Downgraded: Hold
Price Target: n/a
Current: $62.24
Upside: n/a
Mar 11, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.7948
Upside: n/a
Feb 10, 2016
Initiated Coverage: Buy
Price Target: n/a
Current: $80.77
Upside: n/a
Jul 24, 2014
Downgraded: Hold
Price Target: $75 → $85
Current: $236.90
Upside: n/a
May 5, 2014
Upgraded: Buy
Price Target: n/a
Current: $1.37
Upside: n/a
Dec 19, 2013
Rated: Hold
Price Target: $61 → $46
Current: $11.67
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $255
Current: $1,751.38
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $24
Current: $50.51
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $18
Current: $0.64
Upside: n/a